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to have calciﬁed lesions and more likely to have ACC/AHA Type C
lesions. The MACE rate was non-signiﬁcantly higher for patients
enrolled in a clinical trial versus not (12.6% versus 12.2%, p ¼ 0.8) as
was TVR (6.4% versus 5.6%, p ¼ 0.4). Patients enrolled in clinical trials
had a lower mortality after PCI (0.8% versus 4%, p < .001).
CONCLUSIONS Patients enrolled in clinical trials had a lower mor-
tality rate after PCI than those that were not. Whether this difference
is due to a lower risk proﬁle of this cohort, or the beneﬁts associated
with trial enrollment, including closer follow-up, warrants further
investigation.
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BACKGROUND Clinical trials in the United States tend to enroll
racially homogenous cohorts, thereby limiting generalizability. We
sought to identify correlates of clinical trial enrollment from a large
and racially diverse PCI registry.
METHODS We conducted a single-center study of patients undergoing
PCI between 1/1/2010 and 12/31/2013 (n¼14,075) at the Mount Sinai
Medical Center. We compared demographic, clinical and procedural
characteristics between patients who were and were not enrolled in
clinical trials during this period. Independent correlates of trial
enrollment were identiﬁed using multivariable logistic regression.
RESULTS Patients enrolled in trials (n¼659, 4.69%) were younger and
more likely to present with stable clinical syndromes compared to
their counterparts not enrolled (n¼13,416, 95.32%). African-Americans
and Hispanics were more frequently enrolled while Asians were less
likely to enter trials compared to Caucasians. In terms of PCI proce-
dural characteristics, the enrolled cohort was less likely to undergo
PCI of a saphenous vein graft and have thrombotic lesions (Table).Table. Baseline and procedural characteristics of patients enrolled in clinical trials versus not at Mount Sinai
Hospital, New York.p value Odds ratio95% Conﬁdence
IntervalAge 0.001 0.98 0.97-0.99Hispanics 0.042 1.32 1.01-1.73Prior MI 0.046 0.74 0.55-0.99Dialysis 0.015 0.23 0.07-0.76STEMI 0.005 0.16 0.04-0.57PCI-SVG 0.018 0.09 0.01-0.66Thrombosis 0.011 1.98 1.17-3.36MI: Myocardial Infarction; PCI-SVG: Percutaneous Coronary Intervention- Saphenous Vein Graft; STEMI: ST-
Segment Elevation Myocardial Infarction
CONCLUSIONS Patients enrolled in clinical trials differ substantially
from those not enrolled in terms of their baseline demographics,
clinical presentation, and procedural parameters, highlighting the
limited generalizability of trial results to real-world populations.
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BACKGROUND The 2-stenting technique has been regarded to show
worse clinical outcomes than the 1-stenting technique after bifurca-
tion PCI with 1st generation DES. However, there has been paucity of
data comparing 1- and 2-stenting techniques with the use of 2nd
generation DES. Therefore, we sought to investigate the differential
clinical outcomes after PCI for coronary bifurcation lesions with 1- or
2-stenting techniques using 1st or 2nd generation drug-eluting stent
(DES).
METHODS Patient-level pooled analysis was performed with 3,162
patients undergoing PCI using 1st or 2nd generation DES for bifurca-
tion lesions from the ’Korean Bifurcation Pooled Cohorts’ (COBIS II,
EXCELLENT, and RESOLUTE-Korea registry). The 3-year clinical out-
comes were compared between 1- and 2-stenting techniques, strati-
ﬁed by the type of DES.
RESULTS With 1st generation DES, rates of target lesion failure (TLF)
or patient-oriented composite outcome (POCO, a composite of all
death, any MI, any repeat revascularization, and cerebrovascular ac-
cidents) at 3-year were signiﬁcantly higher after 2-stenting than 1-
stenting technique (TLF: 8.6% vs. 17.5%, p<0.001; POCO 18.1% vs.
28.5%, p<0.001). With 2nd generation DES, however, there was no
difference between 1- and 2-stenting techniques (TLF: 5.4% vs. 5.8%,
p¼0.768; POCO: 11.2% vs. 12.9%, p¼0.995). The differential impacts of
2-stenting technique on the prognosis according to the type of DES
were also corroborated with similar results by the inverse probability
weighted model. The 2-stenting technique was a signiﬁcant inde-
pendent predictor of TLF in 1st generation DES (HR 2.046, 95% CI
1.114-3.759, p<0.001), but not in 2nd generation DES (HR 0.667, 95%
CI 0.247-1.802, p¼0.425).
B184 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5CONCLUSIONS Our patient-level pooled analysis of 3-years clinical
results of 3,162 patients in Korean Bifurcation Pooled Cohorts
demonstrated that 2-stenting technique showed comparable out-
comes to 1-stenting with 2nd generation DES, which is different from
the results of 1st generation DES favoring 1-stenting technique. Such
an improved performance of 2nd generation DES even after complex
technique for bifurcation lesions may provide room for more aggres-
sive approach for the selected bifurcation lesions with appropriate
anatomy, rather than universal application of the 1-stenting strategy.
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BACKGROUND Emergency coronary artery bypass grafting (CABG) for
unsuccessful percutaneous coronary intervention (PCI) is now rare.
We aimed to evaluate the current safety and outcomes of primary PCI
and non-primary PCI at centers with and without on-site surgical
backup.
METHODS We performed an updated systematic review and meta-
analysis using mixed-effects models. Randomized controlled trials
(RCT) or prospective observational studies with adjustment of base-
line differences, which compared all-cause mortality or emergency
CABG rates of PCI performed at centers with or without on-site sur-
gical back-up, were identiﬁed. The primary outcome was all-cause
mortality after PCI. Secondary outcomes were rates of emergency
CABG and various complications during or after PCI. Odds ratios (OR)
with 95% conﬁdence intervals (CI) between with and without on-site
surgical back-up were compared.
RESULTS We included 23 high-quality studies that compared clinical
outcomes and complication rates of 1,101,123 patients after PCI at
centers with or without on-site surgery. For primary PCI for ST-
segment elevation myocardial infarction (133,574 patients), all-cause
mortality (without on-site surgery vs. with on-site surgery: observed
rates, 4.8% vs. 7.2%, pooled OR 0.99, 95% CI 0.91-1.07, p¼0.729,
I2¼3.4%) or emergency CABG rates (observed rates, 1.5% vs. 2.4%,
pooled OR 0.76, 95% CI 0.56-1.01, p¼0.062, I2¼42.5%) did not differ by
presence of on-site surgery. For non-primary PCI (967,549 patients),
all-cause mortality (observed rates, 1.6% vs. 2.1%, pooled OR 1.15, 95%
CI 0.94-1.41, p¼0.172, I2¼67.5%) and emergency CABG rates (observed
rates, 0.5% vs. 0.8%, pooled OR 1.14, 95% CI 0.62-2.13, p¼0.669,I2¼81.7%) were not signiﬁcantly different. PCI complication rates
(cardiogenic shock, stroke, aortic dissection, tamponade, recurrent
infarction) also did not differ by on-site surgical capability. Cumula-
tive meta-analysis of non-primary PCI showed a temporal decrease of
the effect size (OR) for all-cause mortality after 2007.
CONCLUSIONS Clinical outcomes and complication rates of PCI at
centers without on-site surgery did not differ from those with on-site
surgery, for both primary and non-primary PCI. Temporal trends
indicated improving clinical outcomes in non-primary PCI at centers
without on-site surgery.
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BACKGROUND Geographical miss is a descriptive terminology for a
poorly deployed coronary stent and the STLLR trial, which looked
speciﬁcally this issue, proved the incidence is very high, an aston-
ishing 65% ending with a signiﬁcantly higher risk for restenosis,
target-lesion revascularization (TLR), MI, and stent thrombosis. Yet,
the mechanism for this shocking stent plaque dissociation rates, re-
mains to be clariﬁed.
METHODS The cyclic movement of the heart and the coronary arteries
induces relative axial movement between the artery and a pre-
deployed intra-luminal device which may cause mal-positioning of
these devices. The exact nature and extent of this phenomenon is not
